1 Supercharged Growth Stock Poised to Trounce the S&P 500

In the first part of the 21st century, value stocks handily outperformed growth stocks in the United States. However, a sharp trend reversal began to take hold after the 2008 financial crisis -- one that holds till this day. Namely, growth stocks, particularly large-cap U.S. firms, have markedly outperformed value stocks over the past 16 years. The chart below lays this pattern bare.

1 supercharged growth stock poised to trounce the s&p 500

VUG

Interestingly, small- and mid-cap growth stocks have largely lagged behind the benchmark S&P 500 index over this period, underscoring the market's emphasis on large-cap entities. When the Federal Reserve eventually cuts interest rates, though, small- and mid-cap equities should have their moment in the sun. After all, most smaller firms are sensitive to interest rates due to their reliance on debt instruments for funding.

1 supercharged growth stock poised to trounce the s&p 500

Growth chart with upward arrow.

Which growth stocks stand out as top market-beating candidates leading into this all-important catalyst? Medical imaging specialist Nanox (NASDAQ: NNOX) has the ingredients to be a top performer in the stock market over the current decade. After all, interest rates tend to go hand-in-hand with the market's appetite for risk. Read on to find out more about this intriguing medical technology growth stock.

Revolutionizing medical imaging: Nanox's innovative approach

In the ever-evolving landscape of medical technology (medtech), Nanox is making waves with its groundbreaking solutions. The company's multi-source digital tomosynthesis system Nanox.ARC and its Nanox.AI platform are poised to transform the field of medical imaging, making advanced diagnostic services more accessible worldwide.

Nanox's technology aims to streamline medical imaging processes, reducing costs and enhancing efficiency. The medtech's platform enables faster and more accurate diagnoses by optimizing workflows and minimizing resource-intensive steps. Most importantly, Nanox's more efficient process ought to improve patient outcomes.

One of the company's key attributes is its cloud-based infrastructure. Nanox uses cloud computing to store and process imaging data, allowing radiologists to access and analyze images remotely. This innovation creates a decentralized healthcare ecosystem that aims to directly address the global shortage of radiologists, especially in developing countries.

What's the opportunity? Nanox is expected to remain cash-flow-negative in the short term, but profitability is a real possibility by 2026. After all, the company is staring down a multi-billion-dollar marketplace with few real competitors.

So, with a market cap of only $503 million, this medtech stock has a decent shot at going on a multi-year bull run, which could deliver gains significantly above those of the broader market. That said, execution will be critical to Nanox's success. Regulatory setbacks or slow adoption rates could hamper share price appreciation in a big way.

Like the story but not the risk profile?

Early commercial-stage medtech companies are inherently risky. Nanox, for its part, is particularly risky because the company is attempting to develop a cutting-edge medical imaging platform.

One way to get exposure to Nanox's stellar upside potential without its equally hefty risk profile is to buy an exchange-traded fund (ETF) that owns a stake in the medtech.

In this regard, two ETFs stand out:

  • iShares Russell 2000 ETF
  • iShares Russell 2000 Value ETF

Both funds hold positions in Nanox at the time of this writing.

These two growth ETFs are somewhat volatile due to their focus on innovation companies. However, each fund is considerably less risky than directly owning shares of Nanox.

Should you invest $1,000 in Nano-X Imaging right now?

Before you buy stock in Nano-X Imaging, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Nano-X Imaging wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $584,435!*

Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than quadrupled the return of S&P 500 since 2002*.

See the 10 stocks »

*Stock Advisor returns as of May 13, 2024

George Budwell has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

OTHER NEWS

4 hrs ago

TWFG Insurance makes US IPO filing public

4 hrs ago

Protestors Gain Entry Into Parliament, Eat Buffet From Restaurant

4 hrs ago

European Investment Bank steps up multi-billion euro defence investments

4 hrs ago

Analysis-Engine maker's Boeing dilemma seen weighing on Airbus output revision

4 hrs ago

Lithuanian conscription: fortifying NATO's flank?

4 hrs ago

Exclusive-Doordash held talks with UK's Deliveroo on takeover, sources say

4 hrs ago

Will MicroStrategy Be a Trillion-Dollar Stock by 2030?

4 hrs ago

#CHIVIDO2024: Stars align as Davido, Chioma tie the Knot

5 hrs ago

Tinubu’s student loan, coastal highway project were my ideas – Sowore

5 hrs ago

Watch me run across the narrowest 3-country salient in the world (First person to EVER document)

5 hrs ago

President Ruto expected to address the nation at 9pm

5 hrs ago

Obi preaches reconciliation as NLC disrupts Abure’s NWC meeting

5 hrs ago

New Attenborough portrait by Jonathan Yeo unveiled

5 hrs ago

Fed's Cook: 'At some point' it will be time to cut interest rates

5 hrs ago

Njeri Maina, Kirinyaga Woman Rep, Criticizes Pressure to Back Finance Bill

5 hrs ago

FTSE 100 slides as investors wary ahead of data and election

5 hrs ago

Nike set for weak quarterly sales growth as On, Hoka chip away market share

5 hrs ago

Nasdaq, S&P 500 open higher as Nvidia firms after selloff

5 hrs ago

Transfer: Cesc Fabregas to sign Chelsea player for Como

5 hrs ago

VIDEO: Hamas Chief Ismail Haniyeh's Family Killed By Israeli Warplanes In a Dramatic Gaza Blitz

5 hrs ago

Crazy Town singer Shifty Shellshock dies aged 49

5 hrs ago

EPL: Details of Ten Hag’s new Man Utd contract emerge

5 hrs ago

Central banks must prepare for profound impact of AI, BIS says

5 hrs ago

China urges EU to revoke sanctions on Chinese firms over Russian links

6 hrs ago

Ogier withdraws from WRC Rally Poland after reconnaissance crash

6 hrs ago

ECB could take action against firms in bond portfolio in climate fight

6 hrs ago

Mark Cuban: Why Curiosity Makes You More Money

6 hrs ago

Sri Lanka likely to sign bilateral debt agreements on Wednesday, foreign minister says

6 hrs ago

Don’t use Nnamdi Kanu’s detention for economic gain – Deputy Speaker, Kalu warns

6 hrs ago

Eleventh-hour push for deal on ‘radical’ GMO deregulation

6 hrs ago

Carbon price for homes and cars could prove ‘very controversial’, senior EU official admits

6 hrs ago

Mining giant Rio Tinto promises "radical transparency" in Serbia

6 hrs ago

Don't sign Finance Bill to law - Catholic Bishops tell Ruto

6 hrs ago

UNESCO proposes putting Stonehenge on 'danger' list

6 hrs ago

Rivers Crisis: Intervene, end it now – Clark to Tinubu

6 hrs ago

Machakos county assembly set on fire

6 hrs ago

European shares fall as Airbus leads aerospace sell-off

6 hrs ago

Reports: Lakers prep pitch, 3-year max deal for LeBron James

6 hrs ago

Morning Bid: Tech rout drives flight to value

6 hrs ago

Russia: President Putin meets with Russian Foreign Ministry officials